Several studies have demonstrated that DQS can promote aqueous and lipid secretion, promote mucin secretion, improve tear film stability, promote epithelial repair, inhibit ocular surface inflammation, and relieve subjective discomfort (35, 36), which promises to solve dry eye after FS-LASIK. Here, MUC5AC is linked to dry eye syndrome.